Search

Author/Creator Dixit, Neha

1. 355 First-in-human phase I study of NKTR-255 in patients with relapsed/refractory hematologic malignancies. (10th December 2020)

Authors:
Shah, Nina; Tan, Alan; Budde, Lihua; Hofmeister, Craig; Cowan, Andrew; Saeed, Hayder; Ye, Jing; Cairo, Mitchell; Rizzieri, David; Orloff, Gregory; Ge, Xue Snow; Lee, Zachary; Dixit, Neha; Nieves, Wildaliz; Vimal, Mona; Ma, Haijun; Miyazaki, Takahiro; Madakamutil, Loui; Marcondes, Mario; Lin, Wei
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A216
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Baseline T cell dysfunction by single cell network profiling in metastatic breast cancer patients. Issue 1 (11th July 2019)

Authors:
Formenti, Silvia C.; Hawtin, Rachael E.; Dixit, Neha; Evensen, Erik; Lee, Percy; Goldberg, Judith D.; Li, Xiaochun; Vanpouille-Box, Claire; Schaue, Dörthe; McBride, William H.; Demaria, Sandra
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 7:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. OP0195 SELECTIVE EXPANSION OF REGULATORY T-CELLS IN HUMANS BY A NOVEL IL-2 CONJUGATE T-REG STIMULATOR, NKTR-358, BEING DEVELOPED FOR THE TREATMENT OF AUTOIMMUNE DISEASES. (June 2019)

Authors:
Fanton, Christie; Siddhanti, Suresh; Dixit, Neha; Lu, Lin; Gordi, Toufigh; Dickerson, Daniel; Zalevsky, Jonathan; Kotzin, Brian
Journal:
Annals of the rheumatic diseases
Issue:
Volume 78(2019)Supplement 2
Page Start:
172
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗